Bamlanivimab EUA - High Risk Criteria • BMI ≥ 35 • Chronic kidney disease • Diabetes • Immunosuppressive disease • Receiving immunosuppressive treatment • Age ≥ 65 years • Age ≥ 55 years AND have any of the following: Cardiovascular disease, Hypertension, COPD/other chronic respiratory disease #Bamlanivimab #EUA #Criteria #covid19 #coronavirus #management
